CARM1 and glioblastoma: Our work demonstrates that loss of CARM1 causes a reduction in GSC cell proliferation and gives support to the proposal that CARM1 should be further investigated as a therapeutic target in Glioblastoma, perhaps focusing on the stem-like population.